Industry News

Vertex Announces Acquisition Deal with Alpine Immune Sciences

Vertex acquires Alpine Immune Sciences for USD 4.9 billion in cash, advancing IgA nephropathy treatment with povetacicept, a dual BAFF/APRIL antagonist, entering Phase 3 development in 2024.

USDA Unveils $1.5 Billion Funding for Conservation Initiatives

USDA announces USD 1.5 Billion for RCPP, boosting climate-focused conservation projects. Farmers, landowners invited to propose solutions till July 2, 2024.

UCI Health Finalizes Acquisition of Four Tenet Hospitals

UCI Health acquires four Tenet hospitals in Orange and Los Angeles counties, expanding services. Tenet's recent USD 975 Million deal follows multiple hospital sell-offs, hinting at over USD 1 Billion in forthcoming funds.

FDA Gives Green Light to Janssen and Legend Biotech's Carvykti for Broader Use in Early-Stage Multiple Myeloma

UCI Health acquires four Tenet hospitals in Orange and Los Angeles counties, expanding services. Tenet's recent USD 975 Million deal follows multiple hospital sell-offs, hinting at over USD 1 Billion in forthcoming funds.

Partnership Between Manipal Hospitals and Pfizer Aims to Enhance Patient Care

Manipal Hospitals' collaboration with Pfizer for adult vaccination marks a proactive step towards preventive healthcare. With a Center of Excellence inaugurated, this initiative promises enhanced accessibility to vaccines and sets a precedent for targeted, effective healthcare strategies.

Mitsui Chemicals Announces Closure of Phenol Plant at Ichihara Works

Mitsui Chemicals closes Ichihara phenol plant by 2026 due to challenging market conditions. The Basic & Green Materials sector aims for sustainability with alternative materials, ensuring supply stability for customers.

Accenture to acquire CLIMB to expand technology capabilities

Accenture, a global leader in consulting, technology, and outsourcing services, recently announced its agreement to acquire CLIMB, a distinguished technology services provider based in Gunma Prefecture, Japan.

Miltenyi Biotec Inaugurates First Office in India, Unveils Plans for Pioneering Cell and Gene Therapy Center of Excellence

Miltenyi Biotec, a global leader in biomedical solutions, is launching operations in India with a focus on advancing cell and gene therapy. Their new center in Hyderabad aims to train experts and bring innovative therapies to patients, catalyzing India's healthcare progress.

UPM Introduces Exciting Range of New Biostimulant Products

The introduction of UPM Solargo represents a significant step towards sustainable agriculture. Its innovative bio-based approach meets growing demand for eco-friendly solutions, driving expected growth in the agrochemicals market and promoting a greener farming future.

FDA Approves Abbott's Triclip Device, a Breakthrough in Treating Leaky Tricuspid Heart Valves

Abbott's TriClip gains FDA approval for treating tricuspid regurgitation, offering a minimally invasive solution for 1.6 million affected Americans. Results show significant improvements in symptoms and quality of life.

Voydeya Receives US Approval as Additional Treatment for Extravascular Hemolysis in Adult PNH Patients Already on Ravulizumab or Eculizumab

Voydeya (danicopan) approved in the US as add-on therapy to ravulizumab or eculizumab for paroxysmal nocturnal hemoglobinuria (PNH) with extravascular hemolysis (EVH). ALPHA Phase III trial showed efficacy, meeting primary and secondary endpoints. Safety profile includes common adverse events. Restricted program due to infection risk, with Boxed Warning for serious infections.

Polygood Introduces Fully Recycled Plastic Panels to North American Market

The Good Plastic Co., originating from the Netherlands, expands into North America, introducing its Polygood line of recycled-content materials to promote sustainability and meet the region's growing demand for eco-friendly solutions.

Asian Paints Takes Control with Majority Stake Acquisition in Harind Chemicals and Pharmaceuticals

Asian Paints secures majority stake in Harind Chemicals and Pharmaceuticals through staged acquisition over five years, with initial purchase of 51% equity. Acquisition aligns with Asian Paints' growth strategy and innovation focus.

Bristol Myers Squibb's Neoadjuvant Opdivo Regulatory Filings Accepted in U.S. and EU for Resectable Non-Small Cell Lung Cancer Treatment Pathway

Bristol Myers Squibb advances neoadjuvant Opdivo with chemotherapy for resectable NSCLC, with FDA and EMA accepting regulatory filings. Phase 3 trial shows significant EFS improvement and favorable safety profile, reinforcing Opdivo's global impact in oncology.

FDA Approves Ipsen's Onivyde Regimen as Potential First-Line Standard-of-Care Therapy for Metastatic Pancreatic Adenocarcinoma

Ipsen's Onivyde regimen, now FDA-approved as first-line therapy for metastatic pancreatic adenocarcinoma, offers hope for a disease with dismal survival rates. The approval follows successful trials and recognition in treatment guidelines.

Gilead Sciences Enhances Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences' acquisition of CymaBay Therapeutics, highlighted by the addition of seladelpar to its liver portfolio, signals a strategic thrust into addressing unmet needs in primary biliary cholangitis (PBC).

FDA Accepts and Prioritizes Review of Lykos Therapeutics' New Drug Application for MDMA-Assisted Therapy in PTSD

Lykos Therapeutics' MDMA-assisted therapy for PTSD, with FDA priority review, aims to revolutionize mental healthcare. Clinical trials show promise, pending regulatory approval for groundbreaking treatment.

FDA Extends Authorization for Paxlovid Use Until March 8, 2024

FDA revises Paxlovid emergency use authorization, allowing EUA-labeled Paxlovid use until March 8, 2024, shifting thereafter to NDA-labeled Paxlovid for treating mild-to-moderate COVID-19, ensuring continuity and safety.

First-Ever End-to-End Generative AI Quality & Trust Solution Unveiled in Healthcare by CitiusTech

CitiusTech unveils a pioneering Gen AI Quality & Trust solution for healthcare, addressing reliability and credibility needs. Combining software framework with consulting services, it offers automated measures and continuous monitoring.

Nigeria Implements Stricter Regulations on Sourcing Active Pharmaceutical Ingredients for Finished Products

Nigeria mandates sourcing APIs for domestic pharmaceuticals from approved suppliers, ensuring adherence to stringent quality standards. Companies must comply by January 2027 or face regulatory action.